Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nizar Tannir

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Palliative & Supportive Care|March 7, 2017
Interconnection: A qualitative analysis of adjusting to living with renal cell carcinomaIsabel Leal, Kathrin Milbury, Joan Engebretson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2014
Randomized controlled trial of expressive writing for patients with renal cell carcinomaKathrin Milbury, Amy Spelman, Christopher Wood, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2011
Accelerated disease progression in prostate cancer and bone metastases with platelet-derived growth factor receptor inhibition: observations with tandutinibPaul Mathew, Nizar Tannir, Shi-Ming Tu, et al.
The Journal of Urology|September 18, 2010
Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinomaJose A Karam, Kamran Ahrar, Christopher G Wood, et al.
Oncoscience|April 11, 2015
Clinical next generation sequencing of pediatric-type malignancies in adult patients identifies novel somatic aberrationsJorge Galvez Silva, Fernando F Corrales-Medina, Ossama M Maher, et al.
BJU International|September 8, 2007
A phase II trial of gefitinib in patients with non-metastatic hormone-refractory prostate cancerEric J Small, Joseph Fontana, Nizar Tannir, et al.
Urology|October 28, 2008
Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinomaVitaly Margulis, Surena F Matin, Nizar Tannir, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2011
Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosisFederico A Monzon, Karla Alvarez, Lief Peterson, et al.
The Journal of Urology|September 18, 2007
Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histologyWassim Kassouf, Ricardo Sanchez-Ortiz, Pheroze Tamboli, et al.
Psycho-Oncology|February 19, 2015
Posttraumatic stress and depressive symptoms in renal cell carcinoma: association with quality of life and utility of single-item distress screeningSeema Malhotra Thekdi, Kathrin Milbury, Amy Spelman, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Palliative & Supportive Care|March 7, 2017
Interconnection: A qualitative analysis of adjusting to living with renal cell carcinomaIsabel Leal, Kathrin Milbury, Joan Engebretson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2014
Randomized controlled trial of expressive writing for patients with renal cell carcinomaKathrin Milbury, Amy Spelman, Christopher Wood, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2011
Accelerated disease progression in prostate cancer and bone metastases with platelet-derived growth factor receptor inhibition: observations with tandutinibPaul Mathew, Nizar Tannir, Shi-Ming Tu, et al.
The Journal of Urology|September 18, 2010
Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinomaJose A Karam, Kamran Ahrar, Christopher G Wood, et al.
Oncoscience|April 11, 2015
Clinical next generation sequencing of pediatric-type malignancies in adult patients identifies novel somatic aberrationsJorge Galvez Silva, Fernando F Corrales-Medina, Ossama M Maher, et al.
BJU International|September 8, 2007
A phase II trial of gefitinib in patients with non-metastatic hormone-refractory prostate cancerEric J Small, Joseph Fontana, Nizar Tannir, et al.
Urology|October 28, 2008
Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinomaVitaly Margulis, Surena F Matin, Nizar Tannir, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2011
Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosisFederico A Monzon, Karla Alvarez, Lief Peterson, et al.
The Journal of Urology|September 18, 2007
Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histologyWassim Kassouf, Ricardo Sanchez-Ortiz, Pheroze Tamboli, et al.
Psycho-Oncology|February 19, 2015
Posttraumatic stress and depressive symptoms in renal cell carcinoma: association with quality of life and utility of single-item distress screeningSeema Malhotra Thekdi, Kathrin Milbury, Amy Spelman, et al.
Pageof 5